The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cancer Tumor Profiling Market Research Report 2025
Synopsis
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
The global Cancer Tumor Profiling market was valued at US$ 39410 million in 2023 and is anticipated to reach US$ 81350 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
This report aims to provide a comprehensive presentation of the global market for Cancer Tumor Profiling, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Tumor Profiling.
Report Scope
The Cancer Tumor Profiling market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Tumor Profiling market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Tumor Profiling companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Segment by Type
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Segment by Application
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Tumor Profiling companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
The global Cancer Tumor Profiling market was valued at US$ 39410 million in 2023 and is anticipated to reach US$ 81350 million by 2030, witnessing a CAGR of 10.4% during the forecast period 2024-2030.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
This report aims to provide a comprehensive presentation of the global market for Cancer Tumor Profiling, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Tumor Profiling.
Report Scope
The Cancer Tumor Profiling market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Tumor Profiling market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Tumor Profiling companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
Segment by Type
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Segment by Application
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Tumor Profiling companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Next-generation Sequencing (NGS)
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In Situ Hybridization (ISH)
1.2.6 Microarray
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Tumor Profiling Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Personalized Medicine
1.3.3 Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Prognostics
1.3.6 Research Applications
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tumor Profiling Market Perspective (2019-2030)
2.2 Cancer Tumor Profiling Growth Trends by Region
2.2.1 Global Cancer Tumor Profiling Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Tumor Profiling Historic Market Size by Region (2019-2024)
2.2.3 Cancer Tumor Profiling Forecasted Market Size by Region (2025-2030)
2.3 Cancer Tumor Profiling Market Dynamics
2.3.1 Cancer Tumor Profiling Industry Trends
2.3.2 Cancer Tumor Profiling Market Drivers
2.3.3 Cancer Tumor Profiling Market Challenges
2.3.4 Cancer Tumor Profiling Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tumor Profiling Players by Revenue
3.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2019-2024)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue
3.4 Global Cancer Tumor Profiling Market Concentration Ratio
3.4.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2023
3.5 Cancer Tumor Profiling Key Players Head office and Area Served
3.6 Key Players Cancer Tumor Profiling Product Solution and Service
3.7 Date of Enter into Cancer Tumor Profiling Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tumor Profiling Breakdown Data by Type
4.1 Global Cancer Tumor Profiling Historic Market Size by Type (2019-2024)
4.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2025-2030)
5 Cancer Tumor Profiling Breakdown Data by Application
5.1 Global Cancer Tumor Profiling Historic Market Size by Application (2019-2024)
5.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Tumor Profiling Market Size (2019-2030)
6.2 North America Cancer Tumor Profiling Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Tumor Profiling Market Size by Country (2019-2024)
6.4 North America Cancer Tumor Profiling Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Tumor Profiling Market Size (2019-2030)
7.2 Europe Cancer Tumor Profiling Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Tumor Profiling Market Size by Country (2019-2024)
7.4 Europe Cancer Tumor Profiling Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Tumor Profiling Market Size (2019-2030)
8.2 Asia-Pacific Cancer Tumor Profiling Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Tumor Profiling Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Tumor Profiling Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Tumor Profiling Market Size (2019-2030)
9.2 Latin America Cancer Tumor Profiling Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Tumor Profiling Market Size by Country (2019-2024)
9.4 Latin America Cancer Tumor Profiling Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Tumor Profiling Market Size (2019-2030)
10.2 Middle East & Africa Cancer Tumor Profiling Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Tumor Profiling Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Tumor Profiling Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Detail
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2019-2024)
11.1.5 Qiagen N.V. Recent Development
11.2 Roche Molecular Systems Inc.
11.2.1 Roche Molecular Systems Inc. Company Detail
11.2.2 Roche Molecular Systems Inc. Business Overview
11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction
11.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2019-2024)
11.2.5 Roche Molecular Systems Inc. Recent Development
11.3 Abott Molecular
11.3.1 Abott Molecular Company Detail
11.3.2 Abott Molecular Business Overview
11.3.3 Abott Molecular Cancer Tumor Profiling Introduction
11.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2019-2024)
11.3.5 Abott Molecular Recent Development
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Detail
11.4.2 Illumina Inc. Business Overview
11.4.3 Illumina Inc. Cancer Tumor Profiling Introduction
11.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2019-2024)
11.4.5 Illumina Inc. Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Detail
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction
11.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2019-2024)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 HTG Molecular Diagnostic
11.6.1 HTG Molecular Diagnostic Company Detail
11.6.2 HTG Molecular Diagnostic Business Overview
11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction
11.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2019-2024)
11.6.5 HTG Molecular Diagnostic Recent Development
11.7 Genomic Health Inc.
11.7.1 Genomic Health Inc. Company Detail
11.7.2 Genomic Health Inc. Business Overview
11.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction
11.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2019-2024)
11.7.5 Genomic Health Inc. Recent Development
11.8 Hologic Gen-Probe
11.8.1 Hologic Gen-Probe Company Detail
11.8.2 Hologic Gen-Probe Business Overview
11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction
11.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2019-2024)
11.8.5 Hologic Gen-Probe Recent Development
11.9 BD Biosciences
11.9.1 BD Biosciences Company Detail
11.9.2 BD Biosciences Business Overview
11.9.3 BD Biosciences Cancer Tumor Profiling Introduction
11.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2019-2024)
11.9.5 BD Biosciences Recent Development
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Detail
11.10.2 Siemens Healthineers Business Overview
11.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction
11.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2019-2024)
11.10.5 Siemens Healthineers Recent Development
11.11 Claris Life Sciences
11.11.1 Claris Life Sciences Company Detail
11.11.2 Claris Life Sciences Business Overview
11.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction
11.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2019-2024)
11.11.5 Claris Life Sciences Recent Development
11.12 Personal Genome Diagnostics, Inc.
11.12.1 Personal Genome Diagnostics, Inc. Company Detail
11.12.2 Personal Genome Diagnostics, Inc. Business Overview
11.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction
11.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2019-2024)
11.12.5 Personal Genome Diagnostics, Inc. Recent Development
11.13 Perthera, Inc.
11.13.1 Perthera, Inc. Company Detail
11.13.2 Perthera, Inc. Business Overview
11.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction
11.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2019-2024)
11.13.5 Perthera, Inc. Recent Development
11.14 Foundation Medicine, Inc
11.14.1 Foundation Medicine, Inc Company Detail
11.14.2 Foundation Medicine, Inc Business Overview
11.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction
11.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2019-2024)
11.14.5 Foundation Medicine, Inc Recent Development
11.15 V., Strand
11.15.1 V., Strand Company Detail
11.15.2 V., Strand Business Overview
11.15.3 V., Strand Cancer Tumor Profiling Introduction
11.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2019-2024)
11.15.5 V., Strand Recent Development
11.16 ApoCell
11.16.1 ApoCell Company Detail
11.16.2 ApoCell Business Overview
11.16.3 ApoCell Cancer Tumor Profiling Introduction
11.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2019-2024)
11.16.5 ApoCell Recent Development
11.17 Contextual Genomics
11.17.1 Contextual Genomics Company Detail
11.17.2 Contextual Genomics Business Overview
11.17.3 Contextual Genomics Cancer Tumor Profiling Introduction
11.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2019-2024)
11.17.5 Contextual Genomics Recent Development
11.18 Agendia
11.18.1 Agendia Company Detail
11.18.2 Agendia Business Overview
11.18.3 Agendia Cancer Tumor Profiling Introduction
11.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2019-2024)
11.18.5 Agendia Recent Development
11.19 GenScript
11.19.1 GenScript Company Detail
11.19.2 GenScript Business Overview
11.19.3 GenScript Cancer Tumor Profiling Introduction
11.19.4 GenScript Revenue in Cancer Tumor Profiling Business (2019-2024)
11.19.5 GenScript Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cancer Tumor Profiling Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Next-generation Sequencing (NGS)
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In Situ Hybridization (ISH)
Table 6. Key Players of Microarray
Table 7. Key Players of Others
Table 8. Global Cancer Tumor Profiling Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Cancer Tumor Profiling Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Cancer Tumor Profiling Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Cancer Tumor Profiling Market Share by Region (2019-2024)
Table 12. Global Cancer Tumor Profiling Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Cancer Tumor Profiling Market Share by Region (2025-2030)
Table 14. Cancer Tumor Profiling Market Trends
Table 15. Cancer Tumor Profiling Market Drivers
Table 16. Cancer Tumor Profiling Market Challenges
Table 17. Cancer Tumor Profiling Market Restraints
Table 18. Global Cancer Tumor Profiling Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Cancer Tumor Profiling Market Share by Players (2019-2024)
Table 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2023)
Table 21. Ranking of Global Top Cancer Tumor Profiling Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Cancer Tumor Profiling Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Tumor Profiling Product Solution and Service
Table 25. Date of Enter into Cancer Tumor Profiling Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Tumor Profiling Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Cancer Tumor Profiling Revenue Market Share by Type (2019-2024)
Table 29. Global Cancer Tumor Profiling Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Cancer Tumor Profiling Revenue Market Share by Type (2025-2030)
Table 31. Global Cancer Tumor Profiling Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Cancer Tumor Profiling Revenue Market Share by Application (2019-2024)
Table 33. Global Cancer Tumor Profiling Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Cancer Tumor Profiling Revenue Market Share by Application (2025-2030)
Table 35. North America Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Cancer Tumor Profiling Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Cancer Tumor Profiling Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2025-2030) & (US$ Million)
Table 50. Qiagen N.V. Company Detail
Table 51. Qiagen N.V. Business Overview
Table 52. Qiagen N.V. Cancer Tumor Profiling Product
Table 53. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 54. Qiagen N.V. Recent Development
Table 55. Roche Molecular Systems Inc. Company Detail
Table 56. Roche Molecular Systems Inc. Business Overview
Table 57. Roche Molecular Systems Inc. Cancer Tumor Profiling Product
Table 58. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 59. Roche Molecular Systems Inc. Recent Development
Table 60. Abott Molecular Company Detail
Table 61. Abott Molecular Business Overview
Table 62. Abott Molecular Cancer Tumor Profiling Product
Table 63. Abott Molecular Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 64. Abott Molecular Recent Development
Table 65. Illumina Inc. Company Detail
Table 66. Illumina Inc. Business Overview
Table 67. Illumina Inc. Cancer Tumor Profiling Product
Table 68. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 69. Illumina Inc. Recent Development
Table 70. NeoGenomics Laboratories Company Detail
Table 71. NeoGenomics Laboratories Business Overview
Table 72. NeoGenomics Laboratories Cancer Tumor Profiling Product
Table 73. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 74. NeoGenomics Laboratories Recent Development
Table 75. HTG Molecular Diagnostic Company Detail
Table 76. HTG Molecular Diagnostic Business Overview
Table 77. HTG Molecular Diagnostic Cancer Tumor Profiling Product
Table 78. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 79. HTG Molecular Diagnostic Recent Development
Table 80. Genomic Health Inc. Company Detail
Table 81. Genomic Health Inc. Business Overview
Table 82. Genomic Health Inc. Cancer Tumor Profiling Product
Table 83. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 84. Genomic Health Inc. Recent Development
Table 85. Hologic Gen-Probe Company Detail
Table 86. Hologic Gen-Probe Business Overview
Table 87. Hologic Gen-Probe Cancer Tumor Profiling Product
Table 88. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 89. Hologic Gen-Probe Recent Development
Table 90. BD Biosciences Company Detail
Table 91. BD Biosciences Business Overview
Table 92. BD Biosciences Cancer Tumor Profiling Product
Table 93. BD Biosciences Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 94. BD Biosciences Recent Development
Table 95. Siemens Healthineers Company Detail
Table 96. Siemens Healthineers Business Overview
Table 97. Siemens Healthineers Cancer Tumor Profiling Product
Table 98. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 99. Siemens Healthineers Recent Development
Table 100. Claris Life Sciences Company Detail
Table 101. Claris Life Sciences Business Overview
Table 102. Claris Life Sciences Cancer Tumor Profiling Product
Table 103. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 104. Claris Life Sciences Recent Development
Table 105. Personal Genome Diagnostics, Inc. Company Detail
Table 106. Personal Genome Diagnostics, Inc. Business Overview
Table 107. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product
Table 108. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 109. Personal Genome Diagnostics, Inc. Recent Development
Table 110. Perthera, Inc. Company Detail
Table 111. Perthera, Inc. Business Overview
Table 112. Perthera, Inc. Cancer Tumor Profiling Product
Table 113. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 114. Perthera, Inc. Recent Development
Table 115. Foundation Medicine, Inc Company Detail
Table 116. Foundation Medicine, Inc Business Overview
Table 117. Foundation Medicine, Inc Cancer Tumor Profiling Product
Table 118. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 119. Foundation Medicine, Inc Recent Development
Table 120. V., Strand Company Detail
Table 121. V., Strand Business Overview
Table 122. V., Strand Cancer Tumor Profiling Product
Table 123. V., Strand Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 124. V., Strand Recent Development
Table 125. ApoCell Company Detail
Table 126. ApoCell Business Overview
Table 127. ApoCell Cancer Tumor Profiling Product
Table 128. ApoCell Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 129. ApoCell Recent Development
Table 130. Contextual Genomics Company Detail
Table 131. Contextual Genomics Business Overview
Table 132. Contextual Genomics Cancer Tumor Profiling Product
Table 133. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 134. Contextual Genomics Recent Development
Table 135. Agendia Company Detail
Table 136. Agendia Business Overview
Table 137. Agendia Cancer Tumor Profiling Product
Table 138. Agendia Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 139. Agendia Recent Development
Table 140. GenScript Company Detail
Table 141. GenScript Business Overview
Table 142. GenScript Cancer Tumor Profiling Product
Table 143. GenScript Revenue in Cancer Tumor Profiling Business (2019-2024) & (US$ Million)
Table 144. GenScript Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Tumor Profiling Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Tumor Profiling Market Share by Type: 2023 VS 2030
Figure 3. Next-generation Sequencing (NGS) Features
Figure 4. Polymerase Chain Reaction (PCR) Features
Figure 5. Immunohistochemistry (IHC) Features
Figure 6. In Situ Hybridization (ISH) Features
Figure 7. Microarray Features
Figure 8. Others Features
Figure 9. Global Cancer Tumor Profiling Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Cancer Tumor Profiling Market Share by Application: 2023 VS 2030
Figure 11. Personalized Medicine Case Studies
Figure 12. Diagnostics Case Studies
Figure 13. Biomarker Discovery Case Studies
Figure 14. Prognostics Case Studies
Figure 15. Research Applications Case Studies
Figure 16. Cancer Tumor Profiling Report Years Considered
Figure 17. Global Cancer Tumor Profiling Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Cancer Tumor Profiling Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Cancer Tumor Profiling Market Share by Region: 2023 VS 2030
Figure 20. Global Cancer Tumor Profiling Market Share by Players in 2023
Figure 21. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tumor Profiling as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2023
Figure 23. North America Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 25. United States Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 29. Germany Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Cancer Tumor Profiling Market Share by Region (2019-2030)
Figure 37. China Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 45. Mexico Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Cancer Tumor Profiling Market Share by Country (2019-2030)
Figure 49. Turkey Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Cancer Tumor Profiling Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 52. Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 53. Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 54. Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 55. NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 56. HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 57. Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 58. Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 59. BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 60. Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 61. Claris Life Sciences Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 62. Personal Genome Diagnostics, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 63. Perthera, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 64. Foundation Medicine, Inc Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 65. V., Strand Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 66. ApoCell Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 67. Contextual Genomics Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 68. Agendia Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 69. GenScript Revenue Growth Rate in Cancer Tumor Profiling Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
